May 10, 2022 / 04:20PM GMT
Travis Lee Steed - BofA Securities, Research Division - MD
Good morning, everybody. I am Travis Steed, the medical device analyst at BofA, and we're thrilled to have Axonics here this morning. We've got both Ray Cohen, CEO; and Dan Dearen, CFO. Welcome.
Raymond W. Cohen - Axonics, Inc. - CEO & Director
Thank you.
Questions and Answers:
Travis Lee Steed - BofA Securities, Research Division - MDSo I just wanted to start off, think through the kind of 1 recovery. I know you had a new product line, so it kind of masks some of that to some degree. So if you think about just looking at your rechargeable device and not the new product, F15, and think about January, February to March and that recovery in March and then -- and how that's kind of improved through April and even into May, does that continue to progress nicely month-to-month?
Raymond W. Cohen - Axonics, Inc. - CEO & Director
Sure. So January was...
Travis Lee Steed - BofA